🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
33.24
-3.78 (-10.21%)
At close: Nov 20, 2026

SHE:301108 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
866.12762.82539.42592.39648.31970.23
Other Revenue
9.199.198.0330.218.2514.22
875.31772.01547.45622.59666.56984.45
Revenue Growth
24.29%41.02%-12.07%-6.60%-32.29%32.50%
Cost of Revenue
682.44584.88448.21442.27461.97667.87
Gross Profit
192.87187.1399.24180.32204.59316.58
Selling, General & Admin
83.9165.1851.4655.6838.9129.1
Research & Development
29.3528.1920.4822.5225.2936.38
Other Operating Expenses
0.11.080.560.724.867.13
Operating Expenses
122.27104.3480.6277.6969.8473.28
Operating Income
70.682.7918.63102.63134.75243.31
Interest Expense
-2.3-1.39-0.77-1.01-1.86-1.62
Interest & Investment Income
16.2618.9615.1730.3824.66.05
Currency Exchange Gain (Loss)
-7.52-7.522.511.226.2-6.89
Other Non Operating Income (Expenses)
-32.41-3.510.78-0.23-0.16-0.24
EBT Excluding Unusual Items
44.6389.3236.32133163.52240.61
Gain (Loss) on Sale of Investments
5.375.355.59.061.011.2
Gain (Loss) on Sale of Assets
0.480.36-0.030.321.150.29
Asset Writedown
-17.77-10.55-17.49-10.51-11.46-0.42
Other Unusual Items
23.352.10.853.137.9510.18
Pretax Income
56.0586.5825.15135.01162.16251.85
Income Tax Expense
1.519.185.9720.4621.231.81
Earnings From Continuing Operations
54.5477.419.17114.54140.97220.05
Minority Interest in Earnings
0-0.130.290.66--
Net Income
54.5577.2719.46115.2140.97220.05
Net Income to Common
54.5577.2719.46115.2140.97220.05
Net Income Growth
3.54%296.97%-83.10%-18.28%-35.94%22.50%
Shares Outstanding (Basic)
11311411411411388
Shares Outstanding (Diluted)
11311411411411388
Shares Change
-18.30%-0.76%0.81%0.14%29.59%2.66%
EPS (Basic)
0.480.680.171.011.242.51
EPS (Diluted)
0.480.680.171.011.242.51
EPS Growth
26.73%300.00%-83.24%-18.39%-50.57%19.32%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
26.49-268.78-21.11-1.54269.1127.59
Free Cash Flow Per Share
0.23-2.37-0.18-0.012.371.46
Dividend Per Share
0.2700.2500.1000.2570.3570.536
Dividend Growth
35.00%150.00%-61.10%-28.00%-33.34%-
Gross Margin
22.04%24.24%18.13%28.96%30.69%32.16%
Operating Margin
8.07%10.72%3.40%16.48%20.21%24.71%
Profit Margin
6.23%10.01%3.56%18.50%21.15%22.35%
Free Cash Flow Margin
3.03%-34.82%-3.86%-0.25%40.37%12.96%
EBITDA
109.69124.0662.83134.32169.16271.94
EBITDA Margin
12.53%16.07%11.48%21.57%25.38%27.62%
D&A For EBITDA
39.0841.2844.231.6934.4128.63
EBIT
70.682.7918.63102.63134.75243.31
EBIT Margin
8.07%10.72%3.40%16.48%20.21%24.71%
Effective Tax Rate
2.69%10.60%23.75%15.16%13.07%12.63%
Revenue as Reported
875.31772.01547.45622.59666.56984.45
Advertising Expenses
-0.080.060.40.180.05